X @Bloomberg
Bloomberg·2026-02-06 11:20
Heated competition among pharma companies over obesity drugs is giving some Novo Nordisk investors flashbacks to the 2017 insulin price wars. https://t.co/Q7lziNnFK7 ...
Heated competition among pharma companies over obesity drugs is giving some Novo Nordisk investors flashbacks to the 2017 insulin price wars. https://t.co/Q7lziNnFK7 ...